Cosmetic treatment, preferably straightening and smoothing of human keratin fibers e.g. hair, comprises applying agent to modulate expression, structure and/or activity of e.g. keratin associated protein7-1 and (ii) protein on fibers
MALGOURIES SYLVAIN,SYLVAIN MALGOURIES,THIBAUT SEBASTIEN,SEBASTIEN THIBAUT,BERNARD BERNARD,BERNARD BERNARD
申请号：
FR1258122
公开号：
FR2994803A1
申请日:
2012.08.30
申请国别(地区):
FR
年份:
2014
代理人:
摘要：
Cosmetic treatment of keratin fibers of a mammal to alter its shape, comprises applying, on the keratin fibers, (i) at least one agent for modulating expression, structure and/or activity of at least one gene and/or protein consisting of e.g. keratin associated protein (KRTAP)7-1 or one agent for modulating expression, structure and/or activity of at least one gene and/or protein consisting of e.g. interfering RNA and (ii) at least one protein consisting of e.g. KRTAP7-1. Cosmetic treatment of keratin fibers of a mammal to alter its shape, comprises applying, on the keratin fibers, (i) at least one agent for modulating expression, structure and/or activity of at least one gene and/or protein consisting of keratin associated protein (KRTAP)7-1, KRTAP8-1, KRTAP13-1, KRTAP19-1, KARTAP19-3, actin alpha -2 (ACTA2), calcium/calmodulin-dependent protein kinase II inhibitor 1 (CAMK2N1), CORIN, endothelin receptor type A (EDNRA), EF-hand domain-containing protein 1 (EFHD1), fatty acid binding protein 4 (FABP4), guanine nucleotide-binding protein-like 3 (GNL3L), GPRC5D, KRBA2, lectin, galactoside-binding, soluble, 3 (LGALS3), LOC339047, NEFL, selenium-binding protein 1 (SELENBP1), SLC05A1, SMA4, TAGLN, zinc finger protein 652 (ZNF652), FKBP1A, pregnancy-associated plasma protein A (PAPPA), retinoic acid receptor responder 1 (RARRES1), SLC35E2, SOX 6 and STON2 or one agent for modulating expression, structure and/or activity of at least one gene and/or protein consisting of interfering RNA, antisense oligonucleotide, monoclonal or polyclonal antibody, aptamer, bosentan, cigfitazone, fasudil, isoproterenol, PD98059, resveratrol, 4-[4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-(4-pyridinyl)-1H-imidazol -2-yl]-3-butyn-1-ol (RWJ 67657), troglitazone, alpha-1, 25-dihydroxy vitamin D3, 15-S-hydroxyeicosatetraenoic acid, batimastat, bisindolylmaleimide, dehydroisoandrosterone, indinavir, lipoate, lysophosphatidic acid, N-Ac-Leu-Leu-norleucinal, nelfinavir, octanoic acid, prostaglandin, F2
